Name | Briquilimab |
---|
Description | Briquilimab (JSP-191) is a non-toxic humanized monoclonal antibody targeting CD117 (c-Kit) to deplete hematopoietic stem cell (HSC). Briquilimab has safety to clear host marrow niche space to enable sufficient donor HSC engraftment and immune reconstitution as primary method of severe combined immunodeficiency (SCID)[1]. |
---|---|
Related Catalog | |
Target |
CD117 (c-Kit)[1] |
References |
No Any Chemical & Physical Properties |